secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001612630-25-000066
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Joint Corp Q3 net income turns positive to $855K; sells 45 clinics for $4.5M; adds $12M buyback
--------------------------------------------------------------------------------

- Q3 revenue $13.4M (+6% YoY); consolidated net income $855K vs loss of $3.2M in Q3 2024.
- Adjusted EBITDA from continuing ops $1.4M vs $262K in Q3 2024; consolidated adjusted EBITDA $3.3M (+36%).
- Agreed to sell 45 Southern California clinics for $4.5M via asset purchase agreement (terms still being negotiated).
- Board authorized additional $12M for stock repurchase program; 540K shares bought for $5M since program start.
- Lowered FY2025 system-wide sales guidance to $530-534M and comp sales to (1)% to 0% from prior low-single-digit growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000161263025000066/0001612630-25-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000161263025000066/jynt-20251102.htm
  HTML page:      https://secwatch.observer/filing/0001612630-25-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer